A Proprietary Operational Framework for Global CEOs, Board Directors & Private Equity Investors
Authored by Yan Zhang (“Lao Tai”)
Former Alibaba Digital Commerce Operator | Scaled Consumer Health Businesses to RMB 100M+ in China
Official Advisory Platform: thechinaos.com | Direct Strategy Inquiries: hello@thechinaos.com
Over the past decade inside Alibaba's platform trenches and advising global consumer brands entering China, I have witnessed world-class Western companies with remarkable products and multi-million-dollar war chests bleed cash and exit within 24 months.
They did not fail because their formulations were inferior. They failed because they attempted to run Western commercial playbooks—built on Google search intent, standalone Shopify stores, independent DTC websites, and passive Amazon shelves—on an entirely different commercial operating system.
In China:
This executive diagnostic white paper condenses the core governance tools from my book, The China Operating System (《掘金中国》), into:
1. The 75-Question Diagnostic Audit: 15 critical strategic domains with 5 non-negotiable stress-test questions each.
2. The 5 Boardroom Operational Worksheets: Ready-to-use executive templates for pre-entry gatekeeping, pilot charters, post-pilot P&L reconciliations, HQ-local alignment, and boardroom budget memos.
Before allocating your next $500,000 to China marketing or signing a master distribution agreement, require your leadership team and local partners to benchmark against these 75 questions.
破除规模幻想与确立入华基准
Core Governance Focus: Replacing abstract population sizing with granular, validated purchasing hypotheses.
[EN] What is the core empirical rationale for entering or restructuring in China today? Strike out '1.4 billion consumers' or 'we sell well in the West.' Formulate a hypothesis specifying which Chinese consumer segment will abandon their current alternative under what exact life trigger to buy from us.
[ZH 原文对照] 我们决定现在进入（或重整）中国市场的核心依据是什么？请把“中国有14亿人”或“我们在欧美卖得很好”划掉，用一句具体到“哪类中国人在什么生活痛点下会放弃现有方案而买我们”的假设来回答。
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] Auditing our existing global brand assets (country-of-origin heritage, clinical literature, patented processes, packaging formats): Which can be perceived directly by Chinese consumers, and which require 'localized translation' to become compelling reasons to buy? Who in the organization is accountable for this translation?
[ZH 原文对照] 盘点我们在海外现有的品牌资产（原产国背书、临床文献、专利工艺、包装形态），哪些可以直接被中国消费者感知，哪些必须经过“本土化转译”才能变成购买理由？这段转译工作目前在组织里由谁具体负责？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] When negotiating with prospective Chinese distributors, Tmall Partners (TPs), or marketing agencies: Are we purchasing 'pure sales execution of pre-validated demand,' or a '0-to-1 exploratory pilot to discover viable buying triggers'? Do contractual terms on testing costs, asset support, and decision rights reflect this reality?
[ZH 原文对照] 当我们与候选的中国总代、代运营（TP）或营销机构谈判时，合同买下的到底是一份“前提已验证的纯销售执行”，还是一段“从0到1共同摸索购买理由的试销合作”？双方对试错成本、资料支持与调整权限的约定是否匹配？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] Require the local team to physically demonstrate the entire consumer journey: From the first impression on a short video or Xiaohongshu note, to Taobao price comparison, livestream Q&A, unboxing, to consuming the final dose. Who owns each handover point where consumer trust can break?
[ZH 原文对照] 请让本地团队现场演示：从一位中国消费者第一次在短视频或笔记里刷到我们，到去淘宝搜索比价、进直播间提问、签收拆盒，直到吃完最后一粒，这中间每一个容易断开的解释环节分别由谁接盘？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] What are the 3 non-negotiable operational KPIs our first-round China budget is meant to validate? Have concrete 'scale-up triggers' and 'hard kill-switch thresholds' been codified in writing in board resolutions to prevent vague 'brand awareness' from masking commercial failure?
[ZH 原文对照] 首轮入华预算最核心要验证的3个业务指标是什么？事先约定的“继续追加条件”与“果断暂停止损红线”是否已白纸黑字写进董事会决议，以防事后用模糊的“品牌声量”掩盖经营失误？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
精准锁定人群与家庭决策痛点
Core Governance Focus: Narrowing focus from broad demographic labels to concrete family purchasing moments.
[EN] Instruct the China team to discard broad labels like '25-45 middle-class urbanites.' Describe our initial seed user in one visceral sentence: Who is buying for whom, at what precise life moment (e.g., child diagnosed with hyperopia reserve depletion, frequent seasonal hospital visits), and what is their deepest anxiety or hesitation?
[ZH 原文对照] 请让中国团队收起“25–45岁一二线城市新中产”这类宽泛标签，用一句具象的话描述我们的第一批种子用户：是谁在什么生活瞬间（如孩子查出远视储备不足、换季频繁跑医院）、替谁购买、当时心里最大的恐惧和纠结是什么？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] Out of our global portfolio of dozens of SKUs, if forced to launch with only ONE flagship hero product (plus at most 1-2 cross-sell items), which do we pick? Have the marginal products chosen to be withheld or cleared been completely removed from local team KPIs?
[ZH 原文对照] 在我们全球现有的几十个SKU中，如果首轮只允许选出1款尖刀产品（最多配1–2款连带品）进入中国，我们选哪一款？那些被决定“暂不引入”或需要清理的边缘产品，是否已从本地团队的年度KPI考核中彻底剔除？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] What concrete proof do we have that the team truly understands this demographic? Have core local operators spent dozens of hours observing target consumers in real-world settings (hospital clinics, offline mother-baby stores, intensive user communities), or are we relying on third-party syndicated research reports?
[ZH 原文对照] 我们凭什么相信团队真懂这群人？本地核心操盘手是否有过在目标人群真实生活场景（如医院门诊、线下母婴店、重度用户社群）里连续观察数十小时的一手体感，还是仅仅看了一份外部买来的行业研报？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] In our preliminary consumer research, did we explicitly seek out 'rejectors'—those who evaluated our product but refused to buy, or bought once and never repurchased? Why are their current alternatives (even doing nothing, taking food remedies, or exercising) perceived as more trustworthy than us?
[ZH 原文对照] 在做前期用户调研时，我们是否专门找过那些“看了我们的产品却最终没买”或“买了一次再也没复购”的拒绝者？他们现有的替代解决办法（哪怕是不吃保健品、改做户外运动或食补）为什么在他们眼里比我们更靠谱？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] When external distribution channels or short-term revenue pressure tempt the team to revert to chasing random trends and diluting focus across multiple demographics, who holds the ultimate veto right to defend our initial strategic focus?
[ZH 原文对照] 当外部渠道或短期营收压力诱惑团队重新回到“什么火卖什么、什么人群都沾一点”的散乱状态时，谁拥有一票否决权来守住首轮聚焦边界？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
监管准入身份与电商流量池匹配
Core Governance Focus: Choosing between Cross-Border E-Commerce (CBEC), General Trade Functional Food, and NMPA Blue Hat.
[EN] For each initial SKU entering China, which regulatory path has been locked (Cross-Border E-Commerce / CBEC, domestic general trade functional food, or registered/filed 'Blue Hat' health food)? Have the corresponding platform category traffic pools and streamer commission restrictions been thoroughly mapped?
[ZH 原文对照] 我们准备引入中国的首批SKU，各自确定走哪条准入路径（跨境电商零售进口、境内普通功能性食品、还是注册/备案“蓝帽子”保健食品）？对应的电商平台一级类目流量池大小与达人带货限制是否已提前摸清？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] If our product carries strong therapeutic or disease-prevention claims in its home market, once stripped of non-compliant claims under Chinese advertising regulations, does the remaining compliant narrative remain sharp enough to command our target premium price point?
[ZH 原文对照] 如果我们的产品在原产国带有强烈的功效或疾病预防宣称，进入中国后按对应监管身份剥离掉不能说的违规词，剩下的合规表达是否依然足够锋利、足以支撑目标客单价？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] Does our Chinese marketing material contain vague or misleading phrasing such as 'FDA Certified' or 'TGA Approved Therapeutic Efficacy'? Can the team produce primary regulatory dossiers distinguishing between factory registration, ingredient safety listings, and finished-product clinical efficacy approvals?
[ZH 原文对照] 我们的中文宣传资料里是否出现了“美国FDA认证”“澳洲TGA批准疗效”等笼统甚至误导性的表述？团队能否逐一拿出原始文件，准确区分“工厂生产备案”“原料安全性列名”与“成品临床功效批准”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] If we simultaneously market cross-border imported versions and domestic general trade versions in China, are ingredient lists, dosage standards, and product detail page narratives completely isolated physically to prevent consumer disputes or regulatory penalties over formulation discrepancies?
[ZH 原文对照] 若我们在中国市场同时销售海外跨境版与境内一般贸易版，两套配料表、剂量标准与详情页话术是否已彻底物理隔离，严防消费者收到货后因版本差异引发投诉或行政处罚？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] Facing China's tightening regulations on live-streamed food marketing, who possesses statutory pre-broadcast veto authority across English literature, Chinese PDPs, and external streamer cue cards? When core claims are blocked by regulations, who has authority to pivot paths or halt commercial rollout?
[ZH 原文对照] 面对2026年施行的食品直播监管新规，从英文文献到中文详情页、再到外部达人的直播手卡，谁拥有法定的“事前合规一票否决权”？当核心卖点因法规受阻时，由谁拍板更换路径或暂停上市？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
识破伪洋牌套路与建立真科研护城河
Core Governance Focus: Competing against domestic-backed ghost foreign brands through transparent, verifiable scientific dossiers.
[EN] 【3-Minute Authentic Origin Dossier】 Facing Chinese top tier streamers and private-domain group leaders traumatized by 'Melbourne auto-repair shop' ghost foreign brands, do we have a 3-minute undeniable proof dossier ready (in-store retail shelf photos in native pharmacies, Google Street View of real labs, native consumer receipts)?
[ZH 原文对照] 【海外真身 3 分钟自证包】 面对被“墨尔本汽修厂”式假洋牌吓怕了的中国头部主播与私域买手，我们是否已经准备好了一套能在 3 分钟内出示的硬核自证材料（包括：原产国主流连锁药房/商超货架的实拍视频、海外实体工厂与研发实验室的连续运转记录、海关原产地证明及全套溯源链路）？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Zero-Exaggeration Certification Audit】 Across our Chinese product pages, PR releases, and streamer cue cards, do we rigorously differentiate between corporate self-filings (e.g., Australian AUST L, US FDA facility registration) and state-approved therapeutic licenses, completely eliminating misleading claims?
[ZH 原文对照] 【跨国认证口径零夸大审计】 我们在中国的详情页、公关稿与主播手卡中，是否严格区分了“企业自我备案列名（如澳洲 AUST L、美国 FDA 工厂登记）”与“官方实质临床审批（如 AUST R、中国蓝帽子）”？是否彻底清除了任何可能被职业打假人或监管部门认定为“概念偷换、虚假宣传”的夸大措辞？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Channel Replacement Pipeline】 Has our commercial team systematically identified top streamers, vertical review accounts, and high-net-worth mother-baby group leaders who recently dropped exposed ghost foreign brands and are urgently seeking authentic, premium foreign replacements?
[ZH 原文对照] 【假洋牌退场后的渠道递补名单】 我们的商务团队是否已经系统梳理了近期因优思益等假洋牌下架而出现选品空缺的头部主持人、垂直评测号与高净值母婴私域团长名单，并针对他们“极度渴求安全正品”的心理定制了专门的登门拜访方案？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Sensory & Delivery Format Leapfrogging】 When benchmarking against leading category competitors in China, are we merely relying on 'brand history,' or have we innovated format delivery (e.g., replacing hard-to-swallow large softgels with burst-liquid enteric technology) to deliver superior physical experience?
[ZH 原文对照] 【对标竞品的剂型与体验反超】 当我们对标中国赛道上的头部竞品时，我们是否只停留在“比拼海外历史”，还是像“用肠衣爆浆软糖反超传统难吞软胶囊”那样，在适口性、独立防潮包装与完服率上做出了让买手一眼惊艳的本土化体验升级？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Tiered Saturated Resonance Deployment】 In penetrating our initial core niche, is our marketing budget still making the mistake of sporadic, isolated influencer tests? Do we have the operational capacity to deploy 10 closely aligned vertical KOCs simultaneously in a coordinated resonance wave?
[ZH 原文对照] 【10人同梯队饱和共振规划】 在切入核心细分人群时，我们的营销预算是否还在犯“零星找一两个达人试水、毫无水花就放弃”的错误？我们是否有能力在新品或大促的 7–14 天关键窗口内，集中调动 10 位同梯队的垂直公信力达人形成饱和式的圈层心智共振？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
本土化微创新、气候适应与感官闭环
Core Governance Focus: Adapting packaging, swallowability, and sensory cues for China's regional climates and family dynamics.
[EN] In our target category, is the 'purchaser' distinct from the 'actual consumer'? If split (e.g., mother buying for child/elderly), does our packaging design address the purchaser's safety anxiety while eliminating the consumer's taste, texture, and swallowing resistance?
[ZH 原文对照] 在我们的目标品类中，“掏钱买单的人”与“实际使用的人”是不是同一个人？如果存在分离（如父母给孩子买、子女给老人买），产品是否同时解决了买单者的信任顾虑与使用者的感官障碍？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Climate & Storage Stress Test】 Has our packaging undergone stress testing under Southern China's humid monsoon season and Northern winter heating conditions? Are bare bulk gummies or hygroscopic tablets prone to clumping, melting, or oxidation, necessitating nitrogen-flushed individual sachets or child-resistant press-and-turn caps?
[ZH 原文对照] 现有海外原版商品从冷链/快递签收、拆盒、每次取用、江南梅雨季保存到最后一次用完，最大的物理或心理障碍是什么？这个判断来自一线实地观察，还是办公室里的猜测？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Unboxing & First-Dose Sensory Protocol】 When a consumer unboxes our parcel: Is there excessive packaging waste, unpleasant chemical odors, broken safety seals, or ambiguous dosage instructions? Have we designed an intuitive, comforting first-dose ritual that builds immediate consumption confidence?
[ZH 原文对照] 我们的主打产品放进中国电商快递箱时，单件客单价与毛利能否覆盖物流、防损包材、平台扣点与退货成本？如果算不过账，是否需要像“短保鲜奶改小杯装蛋糕”一样重构线上专供形态？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Cold-Chain & Logistics Unit Economics】 If our product requires cold-chain or short-shelf-life logistics, have we stress-tested reverse logistics return costs and extreme weather spoilage rates? Can unit margins absorb multi-warehouse regional distribution costs?
[ZH 原文对照] 总部与本地团队是否已书面划清“绝对不可妥协的质量底线”与“允许敏捷打样测试的体验变量”？当頂級渠道选品提出合理的微调诉求时，供应链能否在一两周内拿出A/B实物方案？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【User Blind-Test Defect Removal】 Before committing to mass production runs, did we conduct blinded consumer trials with at least 50 native Chinese households? Have all top 3 sensory complaints (e.g., fishy aftertaste, chalky mouthfeel, oversized pill dimensions) been formulated out?
[ZH 原文对照] 拟议的包装或形态改动（如防误开盖、独立小袋、便携装）是否完成了对应版本的稳定性与合规验证？我们准备用哪个对照实验来证明这项改动确实带来了留存或渠道过审增量？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
新品五步验证机制与果断止损红线
Core Governance Focus: Preventing inventory write-offs through staged pilot validation and disciplined product discontinuation.
[EN] 【The Five-Step Validation Protocol】 Is our China launch adhering strictly to the 5-step sequence: Internal Blind Test -> Expert/KOC Trial -> Closed Mother-Baby Community Pilot -> Public Vertical Channel Launch -> Scaled Paid Traffic Acceleration?
[ZH 原文对照] 我们当前正在推进的中国新品或本土化改版项目，正处于“五步验证闸门”的哪一步？进入下一步是凭着扎实的盲测差评修正记录与前置财务粗算表，还是仅仅因为“PPT写完了、上市排期到了”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Discontinuation Discipline】 If an initial production batch sells out purely driven by launch promotional discounts or novelty, but 60-day repurchase rates fall below category benchmark (as occurred with our 10B CFU probiotic gummy), does management have the discipline to halt reorders immediately?
[ZH 原文对照] 面对拟开发的新产品（如把某种成分换一种新潮剂型），它是顺应了中国消费者已有的成熟品类认知，还是需要我们花巨资从零教育市场？在特定生产工艺（如高温、长途储运）下，核心成分的活性与用户的真实体感是否会大打折扣？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Contribution Margin Hurdle】 Does the pilot product generate positive contribution margin after subtracting direct COGS, platform take rates, streamer commissions, and paid traffic spend, or are we subsidizing unsustainable phantom volume?
[ZH 原文对照] 我们的样品打样是否做到了“多家供应商平行比对”与“创始人最后投票”？在回收的50–100份目标家庭试用反馈里，排名第一的具体负面嫌弃是什么，研发团队是怎么改掉它的？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Reverse Logistics Impact】 What is the true post-pilot return and refund rate? If returns exceed 15% in standard e-commerce or 30% in live-streaming, has an immediate root-cause investigation into formulation, packaging, or marketing mismatch been triggered?
[ZH 原文对照] 财务部门是否在立项打样阶段就已经介入粗算？如果按目标售价扣除中国渠道30%–50%的综合佣金、投流费与退货损耗，这款产品的毛利结构还成不成立？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Independent Compliance Sign-Off】 Does our product launch protocol enforce an independent compliance veto that cannot be overridden by commercial sales targets when regulatory risks arise?
[ZH 原文对照] 组织内部是否有明确的“无罪化止损机制”？当第一波试销数据证明某款产品呈现“高成本、弱体感、重教育”特征时，谁有权像砍掉益生菌软糖一样当机立断停止追单，而不是为了摊薄包材成本继续往火坑里印货？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
全渠道控价铁律与水货代购治理
Core Governance Focus: Protecting the authorized price corridor from unauthorized Daigou dumping and rogue platform arbitrage.
[EN] 【Unauthorized Daigou Price Audit】 What is the lowest price for our SKUs currently available on unauthorized Taobao shops, Pinduoduo, and Xianyu? How wide is the discount gap between unauthorized gray-market listings and our official Tmall Flagship benchmark price?
[ZH 原文对照] 在我们宣布正式进入中国（或启动新渠道招商）之前，打开淘宝、京东、拼多多和小红书搜索我们的英文名与中文昵称，消费者此刻看到的最低代购/水货价格是多少？这个价格与我们拟定的官方零售价相差百分之几？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【The Official Anchor Price】 Is our official Tmall Flagship price strong and credible enough to serve as the price anchor, or is it perceived as inflated shelf dressing that drives savvy shoppers to buy from unauthorized discounters?
[ZH 原文对照] 如果淘宝个人店或非授权渠道已经存在七折甚至五折的低价商品，我们凭什么让抖音主播或私域团长相信，他们按官方高价推荐给粉丝不会被打脸“割韭菜”？我们准备了怎样的版本区隔、一物一码溯源或专属权益来化解这个质问？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【SKU & Packaging Differentiation】 Have we created distinct pack sizes, gift sets, or serialized anti-counterfeit QR codes for official channels to physically isolate authorized inventory from gray-market parallel imports?
[ZH 原文对照] 我们的天猫/京东官方旗舰店是否真正立住了“线上百货专柜价格标杆”？各渠道（天猫大促、抖音直播间、私域社群）把优惠券、满减和正装赠品全部折算进去之后，“每单位真实到手价”是否严格处于同一个受控的价格走廊内？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Distributor Price Corridor Agreement】 Do our commercial agreements with cross-border partners mandate a strict minimum advertised price (MAP) and hard margin floor across all retail touchpoints, backed by contractual penalties for price dumping?
[ZH 原文对照] 当海外免税店、原产国批发商向中国市场低价窜货，冲击中国区正常渠道拓展时，全球总部由哪一位高管出面协调跨区供货纪律，而不是让中国区团队独自背负“渠道打不开”的罪名？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Daily Channel Sweeping System】 Does our local team or monitoring agency run daily automated sweeps across all Chinese marketplaces to issue takedown notices for IP infringement and unauthorized merchant listings?
[ZH 原文对照] 在设计渠道价格管控、防窜货溯源与促销审批制度时，是否已将自营渠道价格纪律、差异化货盘分配与《反垄断法》合规审查结合起来，确保控价手段既强硬有效又合法合规？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
看穿千元账本、直播高退货与真实净收益
Core Governance Focus: Deconstructing live-commerce return rates, traffic tolls, and true retained earnings per ¥1,000 GMV.
[EN] 【The ¥1,000 Order Deconstruction】 For every ¥1,000 of gross livestream GMV, what is the exact net cash retained after deducting 40% returns, 30% platform and streamer commissions, COGS, fulfillment, reverse logistics, and paid traffic tolls (Qianchuan)?
[ZH 原文对照] 本地团队或代理商向总部汇报的销售数字，到底停留在“表面支付GMV”，还是已经穿透到了“扣除秒退、14天售后退货、平台扣点、达人佣金、付费投流及逆向物流损耗后的净贡献（Net Contribution）”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【The Same-Day Mixed Streamer Trap】 Are our live-streamed products being pitched alongside cheaper domestic copycats in the same broadcast or within hours, triggering an immediate 30%+ refund wave from price-sensitive consumers?
[ZH 原文对照] 在挑选抖音、快手或小红书达人时，商务团队是否在合同与排期核查中锁死了“同品类竞品排期隔离期（Exclusivity Window）”？我们投下去的钱，买到的究竟是“吃平台短期算法红利的泛流量主播”，还是“真正拥有粉丝信任红利的垂直达人”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Step-Down Commission Ladder】 Have we implemented a disciplined commission step-down model (e.g., moving from 40% initial trial commission down to 15%-20% for regular restocks, and relying on mid-tier KOCs) rather than remaining addicted to extortionate mega-influencer rates?
[ZH 原文对照] 财务部门是否画出了未来6个月的“现金流垫付时间轴”？当大促或专场直播规模翻倍时，提前垫付的工厂备货款与千川投流充值款，会不会在平台回款到账前拉爆公司的营运现金流？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【True Cohort Repurchase Rate】 When calculating customer lifetime value (LTV), are we tracking full-denominator cohort repurchase rates across 90 and 180 days, or conflating temporary promotional surges with true organic loyalty?
[ZH 原文对照] 如果业务部门以“营养品/护肤品靠后续复购赚钱”为由申请批准首单亏损预算，他们能否拿出一张“保留全部未复购流失客作为完整分母”的90天/180天真实新客队列（Cohort）留存表来证明这个假设？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Working Capital & Cash Flow Runway】 Given 30-to-60 day platform settlement cycles and inventory advance commitments, does our local China operation maintain at least 6 months of liquid cash runway isolated from short-term GMV swings?
[ZH 原文对照] 每一轮市场测试在拨款前，是否已明确写下“最高允许亏损额度”与“触发自动叫停的退货率/ROI红线”？当一场直播出现异常高退货率时，团队能否在24小时内定位到具体原因（如达人背刺混播、话术夸大或价格穿底）？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
信任穿透机制、15秒破冰与文献弹药包
Core Governance Focus: Penetrating high-trust mother-baby communities and private buyer networks through scientific credibility.
[EN] 【The 15-Second Break-In Pitch】 Can our brand story, hero ingredient mechanism, and reason to believe be articulated crisply within 15 seconds to a busy community group leader or livestream consumer without relying on corporate jargon?
[ZH 原文对照] 我们当前规划的“私域”预算，面对的到底是品牌自己直接维护的老客群，还是独立渠道主理人（团长/垂直平台）经营的社群？双方在客户归属、复购触达与售后兜底上的边界是否已书面厘清？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【The Three-Tier Scientific Dossier】 Has our clinical literature been translated into three distinct layers: Tier 1 (Raw peer-reviewed papers for medical reviewers), Tier 2 (Infographic clinical summaries for community leaders), and Tier 3 (1-sentence life benefit for end consumers)?
[ZH 原文对照] 面对一个习惯了销售成熟进口大牌的挑剔买手或团长，除了给佣金，我们能否在15秒内通过感官体验（试吃/试用）留住她的注意力，并在接下来30分钟内拿出经得起“学术答辩式”拷问的文献与检测底稿？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Offline Tea-House Defense Protocol】 Are local commercial representatives equipped to undergo rigorous 2-hour scientific interrogations by discerning community leaders and medical professionals, complete with translated dossiers and test reports?
[ZH 原文对照] 我们的渠道拓展是否只停留在“搞定采购总监”？谁来负责穿透到真正在一线面对消费者的核心团长或导购，并现场检验他们能否用合规、准确的大白话复述出产品的核心差异？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Zero-Tolerance Promotional Integrity】 Does our internal compliance code strictly prohibit hyperbolic health promises, ensuring that every claim made in community channels can withstand scrutiny from professional regulatory whistleblowers?
[ZH 原文对照] 为攻克头部信任渠道所投入的大批量寄样、跨城茶馆答疑、工厂溯源接待与定制QA素材，是否已纳入渠道P&L核算？小团队承诺的服务响应标准，在订单爆发后能否稳定兑现而不崩盘？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Peer-to-Peer Advocacy Assetization】 Are organic consumer testimonials and unprompted praises systematically collected, verified, and integrated into our localized sales enablement assets?
[ZH 原文对照] 首场百万级或爆款合作跑通后，哪些是因为渠道原本的粉丝红利和首发促销，哪些是因为产品真实被接受？营销团队是否已将现场被追问最多的Top 20尖锐问题沉淀为可复用的标准渠道弹药库？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
商务谈判风控、选品背调与直播手卡治理
Core Governance Focus: Governing streamer partnerships, avoiding vanity pit fees, and auditing peripheral giveaway safety.
[EN] 【Streamer Audience Due Diligence】 Before paying upfront pit fees (Kengwei Fei), do we audit the streamer's historical audience authenticity, return rate benchmarks in our category, and audience overlap with our target profile?
[ZH 原文对照] 我们的商务拓展（BD）漏斗目前卡在哪一层？团队能否清楚区分“样品寄出后石沉大海（跟进失职）”与“对方试吃试用后因价格或体感拒绝（产品/机制错配）”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Strict Cue Card Governance】 Do external streamers sign binding agreements to adhere strictly to our pre-cleared product cue cards, with severe financial penalties for unscripted efficacy claims that trigger regulatory backlash?
[ZH 原文对照] 面对时间极度碎片化的中国渠道买手，我们的产品能否在15秒内提供无需解释的感官或体验差异？在开发节日定制装或买赠周边（如赠品挂件、容器、玩具）时，是否对赠品执行了与主品同等级的安全与合规检测？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Peripheral Giveaway Safety Audit】 Are complimentary gifts and co-branded promotional items (e.g., metal keychains, insulated cups, stickers) subjected to identical heavy metal, chemical migration, and safety audits as our core ingestible products?
[ZH 原文对照] 在进入头部主播或高公信力评测渠道前，我们在小红书和短视频平台的“买点种草”是否已经铺垫到位？如果现在强行上播，前端自然搜索与转化流速能否撑过直播间的“5分钟算法考核线”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Pure Pay-for-Performance Structuring】 Are we transitioning commercial partnerships away from fixed non-refundable fees toward pure performance-based commissions tied to net delivered revenue after returns?
[ZH 原文对照] 针对2026年施行的食品直播监管新规及平台风控规则，我们的直播手卡、KT板与主播口播稿由谁做独立合规终审？现场出现口误、专业质疑或系统预警时，谁有权当场纠偏或叫停？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Blacklist & Rogue Partner Database】 Does our commercial team maintain an active blacklist of dishonest brokers, fraudulent MCN agencies, and high-return streaming channels to protect marketing capital?
[ZH 原文对照] 达人直播或测评视频产出的优质素材，在合同中是否已明确约定二次剪辑与信息流投放的肖像授权期限？下播14天后的真实退货率与净结算额，是否已回流并修正下一场的排期预算？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
跨国组织协同、双向转译与敏捷中台
Core Governance Focus: Bridging headquarters science and local execution through a high-velocity 4-person China operating hub.
[EN] 【Headquarters-Local Response Latency】 When local China channels identify urgent market feedback (e.g., packaging defect, competitor price attack), can global headquarters review and approve packaging or formulation iterations within 14 days?
[ZH 原文对照] 面对中国市场上便宜一半甚至几分之一的本土同类产品（如59.9元6瓶 vs 59.9元1瓶），我们的团队还在傻傻地跟对手比拼“每毫克成分价格”，还是已经通过重构“生活场景触发器”改变了消费者的购买决策标准？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【The 4-Person Minimalist Hub】 Has our local operation established the core 4-person functional structure: (1) Strategic General Manager, (2) Content & Scientific Translation Lead, (3) Channel & TP Operations Controller, and (4) Independent Compliance & Finance Officer?
[ZH 原文对照] 我们公司内部是否存在一座连接研发与销售的“三层转译资料库”？随便抽查前线正在使用的一句直播间口播话术或小红书种草标题，团队能否在3分钟内向上追溯到对应的底层文献编号与适用条件？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Bilingual Living Translation Matrix】 Do we maintain a shared, living bilingual repository connecting English technical dossiers, Chinese regulatory redlines, and frontline sales arguments to keep both teams fully aligned?
[ZH 原文对照] 我们的商务团队是把一堆生硬的产品说明书直接甩给外部达人让他们“自由发挥创作”，还是由内部营销中台统一打磨好经过合规审核的脚本模版与KT板，再去赋能上千个达人精准分发？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Independent Compliance Veto】 Is our local regulatory and compliance reviewer structurally insulated from commercial sales quotas, possessing unambiguous authority to veto non-compliant campaigns?
[ZH 原文对照] 在总部与中国团队的日常协作中，本地团队改一句符合中国语境的种草文案需要等总部审批几天？如果总部握着审批权，是否同时配置了能在48–72小时内解答本地复杂科学追问的专业支持接口人？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Eliminating Cultural Arrogance】 Does global leadership respect verified frontline Chinese consumer data over personal subjective preferences when evaluating product adaptations and creative assets?
[ZH 原文对照] 当业务冲刺GMV的冲动与科学事实边界发生冲突时（例如主播想在双十一喊一句擦边球的绝地反击口号），组织里哪一个具体岗位拥有不看销售脸色、直接叫停直播话术的“独立熔断权”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
克制型服务、用户劝退机制与复购沉淀
Core Governance Focus: Building unshakeable brand equity by actively discouraging inappropriate purchases and upholding ethical boundaries.
[EN] 【The Honest Boundary Protocol】 Does our customer service and community SOP clearly articulate product boundaries, explicitly instructing reps to dissuade consumers whose expectations exceed what the product can realistically deliver?
[ZH 原文对照] 翻开我们中国区客服与私域顾问的标准话术库（SOP），里面是否明确写出了每一款主打产品“只是退而求其次的辅助方案”的具体边界，以及哪几类消费者应当被明确劝阻“先别买、先调整日常饮食作息或去医院就诊”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Incentivizing Ethical Retention】 When a frontline advisor honestly advises an anxious mother NOT to purchase an unneeded supplement, does our compensation structure reward the advisor for protecting long-term brand equity?
[ZH 原文对照] 如果今天有一位焦虑的母亲带着超出产品能力范围的期待来咨询，我们的客服人员把她诚实地劝退了，现行的薪酬考核制度是在奖励这位客服“替品牌守住了长期信誉”，还是在惩罚他“丢掉了一笔当期订单”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Dignity & Psychologically Safe Packaging】 In unboxing, usage reminders, and return logistics, have we incorporated considerate details that respect consumer privacy and psychological security?
[ZH 原文对照] 像当年老家小店为邻居准备“黑色塑料袋”一样，我们在包装发货、开箱说明、服用提醒与退换货流程中，是否为中国消费者设计了真正照顾其生活体面与心理安全感的细节？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Strict Private Domain Data Governance】 In collecting family health profiles (e.g., child ages, vision metrics, health concerns), do we adhere strictly to minimum-necessary data principles, full transparency, and zero cross-marketing harassment?
[ZH 原文对照] 在收集和管理私域用户家庭健康信息（如孩子年龄、视力情况、女性生理周期等）时，我们是否严格遵循了“最小必要、明确授权、用途透明、严禁越权交叉骚扰”的合规护栏？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Deconstructing Real Repurchase】 When reporting retention metrics to the board, do we distinguish between natural consumption restocks, promotional hoarding artifacts, and authentic cross-category trust migration?
[ZH 原文对照] 当我们向董事会汇报复购数据时，是否清楚拆解了“同款消耗补货”、“大促囤货周期影响”与“跨品类信任迁移”各自的真实占比，并严禁将普通商业复购率包装成医疗功效证明？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
品类有序横向拓展与小红书搜索心智占领
Core Governance Focus: Executing disciplined product line extensions and capturing high-intent search share of voice on Xiaohongshu.
[EN] 【Disciplined Core Line Extension】 When evaluating horizontal SKU expansion (e.g., eye care into iron, growth, or anti-aging), does the new product address real unmet needs of our existing core demographic without cannibalizing established brand equity?
[ZH 原文对照] 我们本轮计划扩充的新品（如从护眼延展到补铁、长高或女性抗衰），是否依然严格围绕同一批核心家庭用户的真实痛点展开？这款新品到底带来了真实的净营收增量，还是仅仅把老客户原本买A产品的预算分流到了B产品上？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Top 50 High-Intent Question Mapping】 On Xiaohongshu, has our team mapped the Top 50 authentic search queries target consumers type before purchasing, establishing structured content assets to intercept high-intent search traffic?
[ZH 原文对照] 面对中国市场上某些存在巨大认知盲区的高潜力品类（如70%女性缺铁却不自知），我们是否找到了像“地中海角豆提取物切入多囊/生理周期痛点”这样既具科学文献支撑、又能产生强体感与高复购的精准破局切口？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Algorithmic Decay Defense】 Do we actively manage Xiaohongshu's 60-day content algorithmic lifecycle, systematically refreshing evergreen search keywords rather than relying on one-off promotional spikes?
[ZH 原文对照] 在小红书这个“消费决策水源地”上，我们的团队是否整理出了目标消费者在购买前最常搜索的 Top 50 真实问题清单？针对平台“60天内容热度下沉”机制，我们是否建立了由 KOL + KOC + KOS（顾问号）+ 官方号 组成的常态化问题占领矩阵？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【AI Generation Governance & Authenticity】 When deploying AI tools to assist in search keyword clustering and content ideation, do we enforce strict safeguards against artificial consumer personas and mandate human verification of underlying scientific facts?
[ZH 原文对照] 在使用AI工具辅助抓取搜索词和批量生成多场景种草内容时，是否执行了严格的“身份透明（严禁员工假冒素人消费者）”与“人工逐条核对底层科学证据”的风控流程？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Radical Transparency on Origins】 To completely dispel Chinese consumer skepticism regarding 'ghost foreign brands' or 'bonded warehouse day-trippers,' do our official brand pages transparently disclose overseas lab facilities, native retail availability, and manufacturing provenance?
[ZH 原文对照] 为了彻底打消中国消费者对“假洋牌/保税区一日游”的戒备心理，我们的官方详情页与渠道背书包里，是否已清晰、诚实地披露了品牌的原产国在售实景、研发归属、实际生产工厂及中外版本差异？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
理性资本配置、严防重资产陷阱与压力测试
Core Governance Focus: Maintaining capital discipline, testing worst-case scenarios, and prioritizing agile OEM contracts over premature fixed CapEx.
[EN] 【Reinvestment Alignment】 As our China operation generates initial operating cash flow, have headquarters and local partners formally aligned on reinvestment priorities (brand and channel equity vs. premature fixed asset expansion)?
[ZH 原文对照] 当我们的中国业务开始产生第一批正向利润与现金流时，总部与本地合作伙伴是否就“下一阶段利润留存与再投资方向（继续投前端品牌渠道 vs. 投后端供应链/重资产）”达成了书面共识？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Heavy Asset vs. Contract Manufacturing Model】 If internal or external partners advocate investing in local manufacturing plants or dedicated packaging lines, have they presented a comparative financial model benchmarking against top-tier contract manufacturers?
[ZH 原文对照] 如果合作方或内部高管提出要在本地投资建厂、买产线或做重大固定资产投入，他们是否拿出了与“继续使用外部顶尖OEM代工/独家包线”同台对比的完整财务模型，并诚实回答了“建厂后会不会锁死我们未来跨剂型创新的自由度”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Extreme Downside Stress Testing】 Does our capital allocation model include stress tests modeling scenarios where front-end order volumes drop 50% or returns spike 10%? Would increased fixed overhead threaten working capital solvency?
[ZH 原文对照] 财务团队提交的再投资压力测试表中，是否包含了“当前端订单比预期低50%、或退货率上升10%”时的最坏情景测算？在那种极端情况下，刚性增加的固定成本会不会在半年内拖垮主营业务？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Four-Bucket Cash Isolation】 Prior to approving major capital outlays, has liquid cash been segregated into: (1) Fulfillment & Return Reserves, (2) Supplier & Channel Payables, (3) Accrued Undistributed Commissions, and (4) 6-Month Operating Cash Cushion?
[ZH 原文对照] 在批准任何大额新投资之前，财务是否已将账面现金严格切分为“待履约与退货准备金”、“应付供应商与渠道款”、“已到期未结算的团队提成/奖金义务”以及“6个月安全运营缓冲金”？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Joint Governance on Major CapEx】 Do corporate bylaws or joint venture agreements establish clear joint veto thresholds for capital expenditures above specific monetary benchmarks, preventing unilateral overexpansion?
[ZH 原文对照] 我们的公司章程或中国区合资/合作协议中，是否为超过一定金额的资本性开支（CapEx）设立了防止“大股东或单一负责人一言堂”的联席否决权与升级决策机制？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
合作治理：合同确权、商标命脉与代理人道德风险
Core Governance Focus: Safeguarding core trademark assets, super-admin account rights, and exit mechanisms before scaling.
[EN] 【Complete Contractual Audit】 Have all promises made to Chinese executives, partners, or general distributors in WeChat chats, emails, or verbal meetings regarding base pay, commissions, rebates, or equity been formalized into legally binding written contracts?
[ZH 原文对照] 立即核查我们与中国区核心高管、合伙人或总代之间的全部沟通记录：是否存在任何在微信、邮件或口头谈判中许诺过的底薪差额、销售提成、返利或期权安排，至今尚未写入具备中国法律效力的正式主合同中？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Precise Net Revenue Definition】 Is the calculation base for sales commissions and partner rebates rigorously defined as net realized revenue after deducting all returns, platform take-rates, influencer commissions, and paid media spend?
[ZH 原文对照] 在我们现行的激励与代理合同里，“销售提成/返利基数”是否已经精确定义到了“扣除全部售后退货、平台扣点、达人佣金与付费投流后的实际到账净额”？双方是否严格执行了每季度签字确认的书面结算单制度？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Timely Accrual & Written Confirmation】 Does financial management enforce quarterly written sign-offs on earned commissions and rebates prior to any discussion of profit retention or reinvestment?
[ZH 原文对照] 如果公司因为扩大再生产或建厂需要暂时留存现金，财务制度是否做到了“先书面确权历史应付提成/分红，再另行协商延期支付或转投资协议”，严禁将历史欠账与未来预算混为一谈？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Absolute Control of Core Digital Assets】 Across Tmall, JD, Douyin, and Xiaohongshu, does our parent company hold direct, unencumbered ownership of official Chinese trademarks, consumer nickname marks, Super Admin store credentials, and customer data assets?
[ZH 原文对照] 今天打开天猫、京东、抖音和小红书后台，我们品牌的中文官方商标、消费者常叫的中文昵称商标、旗舰店最高管理员权限（Super Admin）、以及营销中台沉淀的文献问答库，实际控制权到底握在总部手里，还是攥在外部代运营/总代手里？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
[EN] 【Structured Exit & Inventory Buyback Protocols】 In the event of strategic divergence between global headquarters and local partners, does the existing agreement provide a clean, non-litigious exit framework governing remaining inventory buybacks and seamless channel handovers?
[ZH 原文对照] 假设两年后总部与中国合作伙伴因为战略方向不同（例如一方想继续投品牌、另一方想转向或退出）决定终止合作，现有合同能否在不打官司的前提下，清楚执行剩余库存回购、应收款清算、店铺主体迁移与客户服务平滑交接？
Audit Status: [ ] Verified with Primary Data | [ ] Unverified Assumption | [ ] Critical Risk Identified
(Executive Operational Templates from Chapter 16)
Usage Rule: Any cell lacking verified primary evidence must be explicitly labeled as "Unverified Assumption & Verification Deadline." Never fill blanks with speculative projections.
(进入市场的前提核查表)
| Pre-Entry Prerequisites | Required Primary Deliverables | Release Gate Criteria |
|---|---|---|
| 1. Seed Demographic & Pain-Point Trigger | 50–100 transcripts of authentic buyer/rejector interviews detailing current alternatives and reasons for abandonment. | One sentence clearly articulating “Who buys for whom under what exact life moment,” with marginal SKUs and non-core audiences formally eliminated in writing. |
| 2. Regulatory Identity & Category Traffic Fit | Regulatory confirmation dossier for CBEC, General Trade functional food, or NMPA Blue Hat; platform category traffic pool analysis. | Core reason-to-believe remains compelling once illegal therapeutic claims are stripped; strict physical separation of domestic vs. imported versions. |
| 3. Sensory Experience & Climate Adaptation | Multi-vendor physical OEM prototypes; founder-voted blinded defect correction log; monsoon/humidity and child-resistant cap tests. | Purchaser (e.g., mother) safety anxieties completely eliminated; consumer (e.g., child) sensory/swallowing friction formulated out. |
| 4. Gray-Market Baseline & Price Anchor | Audit of lowest prices across unauthorized Taobao, Pinduoduo, and Xianyu shops; cross-channel post-discount price corridor matrix. | Tmall Flagship anchor price established; dedicated pack sizes, anti-counterfeit QR codes, or channel rights ready to isolate gray-market dumping. |
| 5. Governance, Trademarks & Cash Reconciliation | Single master contract (no unwritten/side agreements); trademark registrations for English, Chinese, and nickname marks; Super Admin credentials verified. | Commissions precisely defined on net collected revenue; quarterly written confirmation protocols and exit terms locked prior to launch. |
(单一渠道/单品有限试销立项单)
| Charter Element | Mandatory Specification & Hard Constraint |
|---|---|
| Single Core Hypothesis to Validate | Narrowed to one observable hypothesis (e.g., “Verify whether anti-counterfeit serialized 180g family pack achieves >15% conversion and positive contribution margin across 3 vertical mother-baby communities”). |
| Test Product, Audience & Channel Type | Exact SKU version number, specification, target persona; channel classified as High-Trust Vertical Reviewer vs. High-Volume Algorithmic Streamer. |
| Comprehensive Loss Budget Cap | Maximum allowable cumulative net loss including product seeding, content production, pit fees, paid traffic (Qianchuan), and reverse logistics. |
| Three-Tier Data Observation Window | T+1 Day: Front-end click-through rate and 5-minute sales velocity; T+14 Days: True post-return rate and competitor mixed-streaming anomalies; T+90/180 Days: Full-denominator cohort repurchase rate. |
| Scale-Up (Green Light) Conditions | Pre-agreed contribution margin threshold after all variable deductions; channel re-booking interest; positive sensory feedback ratio. |
| Kill-Switch (Red Light) Thresholds | Clear quality/safety defects, regulatory warning strikes, unauthorized price collapse, or return rates exceeding threshold (e.g., >30%) trigger immediate, unconditional suspension. |
| Accountable Signatories | Business Project Lead, Marketing Hub Controller, Independent Compliance Officer (Veto Right), Finance Controller, and Final Executive Decision-Maker. |
(试销后真账复盘与去留决议表)
| Audit Dimension | Verified Frontline Evidence (Preserve Negative Facts) | Boardroom Decision |
|---|---|---|
| 1. Sensory Efficacy & Authentic Repurchase | Did real consumer sensory experience outperform established market alternatives? What was the 90-day full-denominator cohort repurchase rate? | Scale Production / Reformulate with Factory / Immediately Discontinue and Liquidate (as with 10B Probiotic Gummy) |
| 2. Channel Trust & Delivery Performance | Did the 15-second hook and 3-tier scientific dossier penetrate core community leaders? Zero quality defects in giveaways and zero regulatory violations? | Upgrade to Annual Strategic Partner / Supply Tier-2 Training & QA / Disqualify Transactional Streamers |
| 3. Full-Funnel True Unit Economics | Gross GMV $\rightarrow$ Minus Returns $\rightarrow$ Minus COGS $\rightarrow$ Minus Platform/Streamer Take $\rightarrow$ Minus Paid Traffic & Return Logistics = Net Retained Cash & Net P&L. | Increase Media Budget to Scale / Restructure Pricing & GWP / Immediately Terminate Paid Traffic Bleed |
| 4. Restrained Service & Trust Retention | Did customer service execute the 4-step lifestyle audit and honest purchase discouragement? Top 50 high-frequency Xiaohongshu consumer search questions mapped? | Reward Ethical Customer Service Staff / Update Multi-Tier (KOL/KOC/KOS/Official) Search Share of Voice Strategy |
| 5. Unverified Residual Blindspots | Which positive results were merely artifacts of promotional launch discounts? What lab test reports or financial audits remain incomplete? | Assign Designated Owner, Budget, and Deadline for Remediation Prior to Authorizing Any Capital Expansion |
(总部与本地高管“75问自查”联席对齐表)
| Alignment Field | Mandatory Specification Recorded in Session |
|---|---|
| Chapter & Question Number | Specify question ID (e.g., Ch07-Q1 Gray-Market Price Audit or Ch11-Q2 3-Tier Scientific Translation) and the budgetary decision it impacts. |
| Current Reality Assessment | Check one status: [A] Verified with Primary Data / [B] Unverified Management Hypothesis / [C] Critical Compliance or Loss Risk. |
| Supporting Primary Artifacts | Attach specific file names, Taobao price-audit screenshots, 50-person blind sensory review logs, or net finance settlement statements. |
| 14-Day Actionable Verification Plan | If marked [B] or [C], detail exact consumer cohorts to interview, channels to test, or accounts to audit within 14 days. Vague entries like 'improve communication' are prohibited. |
| HQ Support & Local Ownership | Name the specific HQ executive responsible for technical dossiers or cross-region price governance, the local operational lead, and the independent compliance officer. |
| Final Session Resolution | Approved for Scale / Limited Pilot Approved / Plan Rejected for Revision / Immediate Stop-Loss Triggered (with next review date locked). |
(提交跨国董事会的一页纸进入决策书)
| Board Deliberation Module | Mandatory Executive Specification |
|---|---|
| 1. Budget Request & Working Capital Guardrails | Specific requested capital expenditure, maximum loss cap, working capital peak exposure, and verified 6-month operating cash cushion isolation. |
| 2. Core Reason to Buy (Why Buy in China) | Initial core purchaser and consumer profile, specific life trigger driving the purchase, and rationale for abandoning existing domestic/imported alternatives. |
| 3. Regulatory Path, Adaptation & Stop-Loss | Locked regulatory path (CBEC vs. General Trade vs. Blue Hat dual-track), climate/sensory adaptation findings, and non-negotiable 5-step stop-loss redlines. |
| 4. Price Corridor & True Channel Contribution | Official Tmall Flagship anchor price vs. gray-market isolation strategy, target high-trust review channels, and post-return unit economics contribution model. |
| 5. HQ-Local Roles & Compliance Veto | Headquarters scientific literature SLA, local marketing hub translation responsibilities, and independent compliance officer veto authority insulated from sales quotas. |
| 6. Milestones & Automatic Kill-Switches | Hard performance milestones at T+30, T+90, and T+180 days (Net Cash Retained and cohort repurchase); automatic capital freeze thresholds upon trigger. |
If your executive team is currently evaluating a China market entry, restructuring an underperforming TP contract, or auditing why your China e-commerce operations are bleeding cash:
Engage in a private 60-minute strategy session directly with Yan Zhang (“Lao Tai”), supported by professional live English/Chinese bilingual executive interpretation.
A two-week, full-funnel operational audit conducted by Lao Tai and our research desk:
© 2026 The China Operating System Advisory Group. All rights reserved. Authorized for internal corporate strategy and board review.